Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107805824A enables metal-free electrochemical cyclization. This reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel patent CN106588673A details efficient synthesis route offering high yield and supply chain stability for pharmaceutical intermediate manufacturing processes globally.
Patent CN110028403A reveals visible light dicarboxylation. Offers mild conditions and scalable succinic acid manufacturing for pharma intermediates.
Patent CN102260273B details novel anti-tumor conjugates. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN100554269C reveals a Lewis acid-catalyzed route for triazole pyrimidines, offering high purity and reduced corrosion for agrochemical intermediate manufacturing.
Patent CN116262673B reveals solvent-free ball milling for alpha-bromoacetophenone. Enhances supply chain reliability and reduces environmental impact for pharmaceutical intermediates.
Novel low-toxicity chlorination route for 2-amino-5-chlorobenzamide. High yield >85%, reduced environmental impact, scalable manufacturing for global supply chains.
Novel Pd/C catalyzed method for PCUD reduction. Enhances supply chain reliability and cost efficiency for high-energy fuel and pharmaceutical applications.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN104530040A reveals high-yield synthesis eliminating phosphorus waste. Reliable supplier offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109280050B reveals a novel avanafil synthesis method offering high purity and cost reduction in pharmaceutical intermediates manufacturing through optimized oxidation steps.
Novel synthesis of lappaconitine acetal derivatives offers mild conditions and high safety for scalable antitumor pharmaceutical intermediates manufacturing supply chains.
Patent CN103012264A details a robust resolution method for (R)-3-amino-hexahydro-1H-azepane using tartaric acid, ensuring superior optical purity for ophthalmic antibiotics.
Patent CN115368238A reveals a catalyst-free visible light method for trans-olefins. Achieves >100:1 stereoselectivity at room temperature, offering significant cost reduction.
Patent CN106632365B reveals a novel one-pot synthesis for high-purity lappaconitine-isatin hybrids, offering significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis of licochalcone A dihydropyrazole derivatives. Mild conditions, scalable process for pharmaceutical intermediates. Reliable supply chain partner for global drug development.
Patent CN109593055B details a scalable resolution method for Brivaracetam isomer (2S, 4S), eliminating chromatography for cost-effective pharmaceutical intermediate manufacturing.
Patent CN109293722B details a novel synthesis for Azithromycin Impurity P using modified platinum carbon catalysis, offering reliable supply for pharmaceutical quality control.
Novel trifluoromethyl xanthone synthesis via methanesulfonic acid cyclization offers high yield antitumor activity for reliable pharmaceutical intermediate supply chains.
Patent CN111153847A details a metal-free three-component tandem reaction for high-purity dihydropyrrole derivatives, offering significant cost reduction in pharmaceutical intermediate manufacturing.